Medication info
Simvastatin Tablets (Simvastatin)

Simvastatin Tablets (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Bivozon Pharmaceutical Co., Ltd.
Appearance
Yellowish-brown oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201600436 · Approved 2016.01.25 · Insurance code 658203020

Summary

Main use
Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Before starting treatment, adjust the dose appropriately according to the initial LDL cholesterol level, treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for the recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Administration to patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this medicine is not excreted to a significant extent by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
Bivozon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and pediatric familial hypercholesterolemia; prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • dysbetalipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. It is beneficial for adult patients at high risk of cardiovascular events due to coronary heart disease, diabetes, peripheral vascular disease, and stroke, and reduces the risk of death from coronary heart disease as well as the occurrence of non-fatal myocardial infarction and stroke. Additionally, it also lowers the risk of coronary and non-coronary vascular interventions. It is used in the treatment of hyperlipidemia, improving levels of total cholesterol and LDL-cholesterol, thus lowering bad lipid values and increasing HDL-cholesterol levels to regulate blood lipid status in conditions such as primary hypercholesterolemia, mixed dyslipidemia, and hypertriglyceridemia. It is also safely used as an adjunct to diet to lower blood lipid levels in pediatric patients with heterozygous familial hypercholesterolemia. It is effective in improving various cardiovascular diseases and dyslipidemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of the risk of cardiovascular disease Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Before starting treatment, adjust the dose appropriately according to the initial LDL cholesterol level, treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) Refer to the information below for the recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, the maximum reduction in cholesterol levels may be achieved with a daily dose of 20 mg of this medicine. (3) Administration to patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered to patients taking verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Administration to patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered to patients taking amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see 2. Do not administer to the following patients under Precautions for Use) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Administration to patients with renal impairment Because this medicine is not excreted to a significant extent by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication may pose a risk of muscle-related abnormalities, so caution should be exercised, especially when taking high doses or combining with other medications. If muscle pain or weakness occurs, notify a doctor immediately, and if symptoms worsen, discontinue use. Do not take if there is a history of liver disease or if liver function test results are abnormal, as this may affect liver function. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication and must discontinue it immediately if pregnancy is confirmed during treatment. There is an increased risk of side effects when taken with certain medications, so inform your doctor or pharmacist if you are taking other drugs. Additional caution is needed for elderly patients or those with impaired kidney function, as well as those with hypothyroidism. This medication may raise blood sugar levels in some patients, so individuals at risk of diabetes should regularly check blood sugar levels. Regular liver function and muscle-related tests should be conducted, and consult a healthcare professional if any unusual symptoms arise. Moreover, avoid substances such as grapefruit juice that inhibit CYP3A4 enzymes, as they may increase the risk of side effects from this medication. Children and adolescents over 10 years old, particularly females who have menstruated for at least a year, are eligible for treatment; it is not recommended for other age groups. Lastly, this medication should only be taken according to a doctor's prescription and instructions, and should be stored out of reach of children.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 93 more
  • upper respiratory tract infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • extraocular muscle movement disorders
  • facial incompleteness paralysis
  • tremors
  • sensory abnormalities
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disturbances
  • nightmares
  • depression
  • cognitive impairment
  • severe muscular weakness
  • ocular muscle weakness
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • progression of cataract
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus-like syndrome
  • rheumatoid polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive anti-nuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • pancreatitis
  • fatal liver failure
  • obstructive jaundice
  • liver fatty change
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • limb sensory dullness
  • tingling
  • cold sensation
  • thrombocytopenia
  • interstitial lung disease
  • muscle weakness
  • myalgia
  • muscle tenderness
  • muscle weakness
  • elevated creatine kinase
  • myoglobinuria
  • acute kidney failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve its effectiveness.

Appearance and packaging

Appearance

Yellowish-brown oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.